Infliximab for Immune Checkpoint Inhibitor Associated AKI

NCT07683975 · clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
44
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Massachusetts General Hospital

Collaborators